N-[[3-(b-D-Glucopyranosyloxy)-2,3-dihydro-2-oxo-1H-indol-3-yl]acetyl]aspartic acid

Metabolite details

Identifier

ANAVISFXAGVRIA-UHFFFAOYSA-N

InChI Key

ANAVISFXAGVRIA-UHFFFAOYSA-N

IUPAC name

2-[[2-[2-oxo-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-indol-3-yl]acetyl]amino]butanedioic acid

Preferred name

N-[[3-(b-D-Glucopyranosyloxy)-2,3-dihydro-2-oxo-1H-indol-3-yl]acetyl]aspartic acid

INN name

—

Synonym

—

ChEBI

CHEBI:184657

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d